142 related articles for article (PubMed ID: 8479289)
1. Reduction of calbindin-28k mRNA levels in Alzheimer as compared to Huntington hippocampus.
Sutherland MK; Wong L; Somerville MJ; Yoong LK; Bergeron C; Parmentier M; McLachlan DR
Brain Res Mol Brain Res; 1993 Apr; 18(1-2):32-42. PubMed ID: 8479289
[TBL] [Abstract][Full Text] [Related]
2. Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels.
Sutherland MK; Somerville MJ; Yoong LK; Bergeron C; Haussler MR; McLachlan DR
Brain Res Mol Brain Res; 1992 Apr; 13(3):239-50. PubMed ID: 1317496
[TBL] [Abstract][Full Text] [Related]
3. Reduction of thyroid hormone receptor c-ERB A alpha mRNA levels in the hippocampus of Alzheimer as compared to Huntington brain.
Sutherland MK; Wong L; Somerville MJ; Handley P; Yoong L; Bergeron C; McLachlan DR
Neurobiol Aging; 1992; 13(2):301-12. PubMed ID: 1387923
[TBL] [Abstract][Full Text] [Related]
4. Specific reduction of calcium-binding protein (28-kilodalton calbindin-D) gene expression in aging and neurodegenerative diseases.
Iacopino AM; Christakos S
Proc Natl Acad Sci U S A; 1990 Jun; 87(11):4078-82. PubMed ID: 2140897
[TBL] [Abstract][Full Text] [Related]
5. Calbindin D28k mRNA in hippocampus, superior temporal gyrus and cerebellum: comparison between control and Alzheimer disease subjects.
Maguire-Zeiss KA; Li ZW; Shimoda LM; Hamill RW
Brain Res Mol Brain Res; 1995 Jun; 30(2):362-6. PubMed ID: 7637586
[TBL] [Abstract][Full Text] [Related]
6. Alteration in levels of expression of brain calbindin D-28k and calretinin mRNA in genetically epilepsy-prone rats.
Montpied P; Winsky L; Dailey JW; Jobe PC; Jacobowitz DM
Epilepsia; 1995 Sep; 36(9):911-21. PubMed ID: 7649131
[TBL] [Abstract][Full Text] [Related]
7. Effect of treatment with the dihydropyridine-type calcium antagonist darodipine (PY 108-068) on the expression of calbindin D-28K immunoreactivity in the cerebellar cortex of aged rats.
Amenta F; Mancini M; Naves FJ; Vega JA; Zaccheo D
Mech Ageing Dev; 1995 Jan; 77(3):149-57. PubMed ID: 7739263
[TBL] [Abstract][Full Text] [Related]
8. Calbindin D-28k and parvalbumin in the rat nervous system.
Celio MR
Neuroscience; 1990; 35(2):375-475. PubMed ID: 2199841
[TBL] [Abstract][Full Text] [Related]
9. Localization and quantitation of 68 kDa neurofilament and superoxide dismutase-1 mRNA in Alzheimer brains.
Somerville MJ; Percy ME; Bergeron C; Yoong LK; Grima EA; McLachlan DR
Brain Res Mol Brain Res; 1991 Jan; 9(1-2):1-8. PubMed ID: 1850065
[TBL] [Abstract][Full Text] [Related]
10. Calcium homeostasis in ageing: studies on the calcium binding protein calbindin D28K.
Lally G; Faull RL; Waldvogel HJ; Ferrari S; Emson PC
J Neural Transm (Vienna); 1997; 104(10):1107-12. PubMed ID: 9503262
[TBL] [Abstract][Full Text] [Related]
11. Coexistence of calcium-binding proteins in vagal and glossopharyngeal sensory neurons of the rat.
Ichikawa H; Helke CJ
Brain Res; 1997 Sep; 768(1-2):349-53. PubMed ID: 9369337
[TBL] [Abstract][Full Text] [Related]
12. Calbindin D-28k immunoreactivity in the rat cerebellar cortex: age-related changes.
Amenta F; Cavalotta D; Del Valle ME; Mancini M; Sabbatini M; Torres JM; Vega JA
Neurosci Lett; 1994 Aug; 178(1):131-4. PubMed ID: 7816322
[TBL] [Abstract][Full Text] [Related]
13. Calbindin-D 28k immunoreactivity in the cerebellum of spinocerebellar degeneration.
Ishikawa K; Mizusawa H; Fujita T; Ohkoshi N; Doi M; Komatsuzaki Y; Iwamoto H; Ogata T; Shoji S
J Neurol Sci; 1995 Apr; 129(2):179-85. PubMed ID: 7608734
[TBL] [Abstract][Full Text] [Related]
14. Expression of calbindin-D decreases with age in intestine and kidney.
Armbrecht HJ; Boltz M; Strong R; Richardson A; Bruns ME; Christakos S
Endocrinology; 1989 Dec; 125(6):2950-6. PubMed ID: 2583050
[TBL] [Abstract][Full Text] [Related]
15. Detection of calbindin-D 28k mRNA in rat vestibular ganglion neurons by in situ hybridization.
Demêmes D; Moniot B; Lomri N; Thomasset M; Sans A
Brain Res Mol Brain Res; 1991 Jan; 9(1-2):153-6. PubMed ID: 1850071
[TBL] [Abstract][Full Text] [Related]
16. Combination of alkaline phosphatase in situ hybridization with immunohistochemistry: colocalization of calretinin-mRNA with calbindin and tyrosine hydroxylase immunoreactivity in rat substantia nigra neurons.
Heppelmann B; Señaris R; Emson PC
Brain Res; 1994 Jan; 635(1-2):293-9. PubMed ID: 7909717
[TBL] [Abstract][Full Text] [Related]
17. Quinolinic acid-induced increases in calbindin D28k immunoreactivity in rat striatal neurons in vivo and in vitro mimic the pattern seen in Huntington's disease.
Huang Q; Zhou D; Sapp E; Aizawa H; Ge P; Bird ED; Vonsattel JP; DiFiglia M
Neuroscience; 1995 Mar; 65(2):397-407. PubMed ID: 7777157
[TBL] [Abstract][Full Text] [Related]
18. Induction of calbindin-D 28K gene and protein expression by physiological stimuli but not in calcium-mediated degeneration in rat PC12 pheochromocytoma cells.
Vyas S; Michel PP; Copin MC; Biguet NF; Thomasset M; Agid Y
FEBS Lett; 1994 Aug; 351(1):53-7. PubMed ID: 8076693
[TBL] [Abstract][Full Text] [Related]
19. Parvalbumin and calbindin D-28K in the human entorhinal cortex. An immunohistochemical study.
Tuñón T; Insausti R; Ferrer I; Sobreviela T; Soriano E
Brain Res; 1992 Aug; 589(1):24-32. PubMed ID: 1422819
[TBL] [Abstract][Full Text] [Related]
20. Opposing effects of ethanol and nicotine on hippocampal calbindin-D28k expression.
Mulholland PJ; Harris BR; Wilkins LH; Self RL; Blanchard JA; Holley RC; Littleton JM; Prendergast MA
Alcohol; 2003; 31(1-2):1-10. PubMed ID: 14615005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
